TrialLipids in health and disease2015

Effect of the DGAT1 inhibitor pradigastat on triglyceride and apoB48 levels in patients with familial chylomicronemia syndrome.

Charles Daniel Meyers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.